Myeloma Flashcards
Myeloma pathophysiology
Bone marrow malignancy causing a clonal population of abnormal plasma cells
They secrete abnormal antibodies - IgG,E,D,M kappa and lambda - paraproteins
Presentation of myeloma
CRAB (end organ damage)
Hypercalcaemia - bone lytic lesions, polyuria, polydipsia, constipation
Renal disease - AKI due to accumulation of complexes
Anaemia - aplastic anaemia - fatigue, SOB
Bone pain - pathological fractures and osteolytic bone lesions
Other:
- recurrent infections - neutropenia
- abnormal bleeding - thrombocytopenia
- hyperviscosity - headaches, visual disturbances
- neuropathy - spinal cord compression
Complications of myeloma
Aplastic anaemia - pancytopaenia
Thrombocytopenia - abnormal bleeding
Bone pain
Renal disease - complexes deposit in the glomerulus
Plasmacytomas
Impaired immune system
Amyloidosis - abnormal antibodies deposited in organs such as the heart
Presentation of hypercalcaemia
Polyuria Polydipsia Abdo pain Constipation Lethargy Confusion
Defining factors of myeloma
SLIM
Sixty percent (60%) bone marrow plasmacytosis
Light chain ratio > 100
MRI - > 1 focal lesion of > 5mm
Must be accompanied by >10% clonal population of bone marrow plasma cells
Myeloma investigations
Bloods - FBC, U+Es, LFTs, Bone profile (Ca2+, phosphate, ALP), vitamin D
Immunoglobulin screen - IgG, M, A - maybe polyclonal or monoclonal
Urine sample - Bence - Jones proteins
Bone marrow biopsy and aspiration - Flow cytometry
Paraprotein detected by electrophoresis
Paraprotein ratio: serum-free light chains (SFLC) - monoclonal protein (M - protein)
CT CAP
MRI - whole body
Important examination for myeloma
Neurological exam - exclude spinal cord compression
Serum-free light chains (SFLC)
Levels of kappa and lambda light chains detected in serum
Gives ratio (if just high kappa - high likelihood of monoclonal population)
Asymptomatic myeloma - smouldering
Paraprotein > 30g/l
Clonal bone marrow plasma cells - 10 - 60%
Absence of any myeloma defining events or amyloidosis
Treatment of myeloma
Intensive - chemotherapy (VTD) + autologous stem cell transplant
Non intensive - chemotherapy
Less than 30% stay in remission
How does myeloma cause anaemia
- Shift from myeloid progenitor to lymphoid progenitor cells
- More plasma cells taking up bone marrow space so less RBC production
- Renal impairment so less erythropoietin
Staining for myeloma
Congo red
VTD
Chemotherapy
Thalidomide
Dexamethasone